You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • THU0418 Denosumab Versus Risedronate: Efficacy and Safety in Postmenopausal Women Suboptimally Adherent to Alendronate Therapy in a Randomized Open-Label Study

Article metrics

Article menu
Download PDFPDF
Poster Presentation
Spondyloarthritis - treatment
THU0418 Denosumab Versus Risedronate: Efficacy and Safety in Postmenopausal Women Suboptimally Adherent to Alendronate Therapy in a Randomized Open-Label Study

 

Online download statistics by month:

Online download statistics by month: February 2014 to February 2024

AbstractFullPdf
Feb 20141303
Mar 2014301
Apr 2014801
May 2014800
Jun 2014300
Jul 2014200
Sep 2014400
Oct 2014300
Nov 2014501
Dec 2014500
Jan 2015100
Feb 2015300
Mar 20151501
Apr 2015300
May 2015100
Jun 2015101
Jul 2015400
Aug 2015500
Sep 2015600
Oct 2015300
Nov 2015600
Dec 2015202
Jan 2016603
Feb 2016400
Mar 2016100
Apr 2016101
May 2016900
Jun 2016800
Jul 2016700
Aug 2016601
Sep 2016200
Oct 2016500
Nov 2016600
Dec 2016400
Jan 2017908
Mar 20171201
Apr 2017700
May 2017200
Jun 2017800
Jul 2017800
Aug 20171200
Sep 20171603
Oct 2017600
Nov 2017800
Dec 20171400
Jan 2018800
Feb 2018400
Mar 2018400
Apr 2018600
May 2018801
Jun 20181200
Jul 2018800
Aug 20181400
Sep 2018400
Oct 2018200
Nov 20181200
Dec 2018600
Feb 20192000
Apr 2019402
May 2019200
Jun 2019200
Jul 2019200
Aug 2019400
Sep 2019200
Oct 2019100
Nov 2019100
Dec 20191602
Feb 2020300
Mar 2020100
Jun 2020200
Jul 2020400
Aug 2020600
Sep 2020800
Oct 2020200
Nov 2020600
Dec 2020400
Jan 2021200
Feb 2021200
Oct 2021400
Nov 2021400
Dec 20211600
Jan 20221000
Feb 2022400
Mar 2022800
Apr 20221200
May 2022600
Jun 2022600
Jul 20222000
Aug 20221000
Sep 2022600
Oct 2022600
Nov 2022600
Dec 2022400
Jan 2023800
Feb 2023400
Mar 2023400
May 2023401
Jun 2023600
Jul 2023200
Aug 2023200
Sep 2023800
Oct 2023200
Dec 2023200
Jan 2024400
Feb 2024200
Total617033